ExSURE PVT. LTD.
The startup operates a biotech platform that utilizes a patented exosome-based drug delivery system to target cancer stem cells, minimizing the toxic effects of chemotherapy. This approach enhances treatment efficacy for cancer patients by delivering therapies directly to affected cells, thereby reducing side effects and improving overall outcomes.
- Biotechnology
Updated 11 months ago
Funding
Raised to date
$358.3KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 2 rounds
B$347K · Seed
Announced Jan 2025
Disclosed cumulative: $347K
Not on chart (date unknown): Seed $11.3K
RoundDateAmountValuationInvestors
Founders
Product
Features
- The startup operates a biotech platform that utilizes a patented exosome-based drug delivery system to target cancer stem cells, minimizing the toxic effects of chemotherapy. This approach enhances treatment efficacy for cancer patients by delivering therapies directly to affected cells, thereby reducing side effects and improving overall outcomes.